hhs_forecastForecastb8snp8hss41
IDIQ for CDER GDUFA research program for brand name and/or generic pharmaceuticals to include small molecule and peptide therapeutics
Department of Health and Human Services.Food and Drug Administration.75F401
- Est. solicitation
- —
- Date posted
- —
- Source
- Open forecast
Description
The Center for Drug Evaluation and Research (CDER), requires Pharmaceutical Manufacturer/Supplier to provide brand name and/or generic pharmaceuticals to include small molecule and peptide therapeutics. A Single award IDIQ contract is anticipated to provide multiple types of pharmaceutical drugs (approximately 75 types) to support the GDUFA research program.
Planning details
- Estimated value
- >= $3M and < $7M
- Anticipated award
- Aug 1, 2026
Classifications
- NAICS325412
- PSC325412